-
Recent studies indicate that semaglutide, marketed as Ozempic and Wegovy, may significantly reduce mortality rates and slow aging in overweight individuals with cardiovascular disease. The drug shows potential benefits beyond weight loss, including lower death rates from various causes, including COVID-19. These findings were presented at the European Society of Cardiology Conference.
-
Kate Moss' half-sister revealed severe health issues after using Ozempic for weight loss. During her podcast, she described experiencing nausea and a seizure due to dehydration, ultimately calling her decision to use the drug 'the worst decision I ever made.' This incident raises concerns about the safety of off-label drug use for weight loss.
-
The former WWE wrestler said he’d gained ‘an uncomfortable amount of weight’ to make ‘Knock at the Cabin’